Hedge Funds Are Selling BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was in 24 hedge funds' portfolio at the end of December.

Keep Reading →